Entellus Medical Announces Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Entellus Medical (ENTL)Posts Q3 Loss of 32c/Share; Updates FY15 Outlook
November 5, 2015 5:07 PM ESTEntellus Medical (NASDAQ: ENTL) reported Q3 EPS of $0.32, versus the analyst estimate of ($0.25). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.19 million.
Entellus Medical sees FY2015 EPS of ($1.12)-($0.99), versus the consensus of ($0.92). Entellus Medical sees FY2015 revenue of... More
